4.16.2020 TDOC Bearish Divergence up to the Monthly TF
Mis à jour
COVID has pumped this stock to overbought.
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.
-NFA
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.
-NFA
Note
4.17.2020 Short
My opinions only not trading advice.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.